In addition to SLC3A2's role in immune typing of BC (Fig. 2H), we found that SLC3A2 remarkably correlated with most chemokines, receptors, immunoinhibitors, immunostimulators, MHC molecules and lymphocytes (Fig. 2I-N). The gene discussed is SLC3A2; the disease is breast cancer.